Navigation Links
Mutant Kras drives pancreatic cancer maintenance via metabolic pathways
Date:4/26/2012

as) and bred it into mice. This allowed the scientists to initiate expression of Kras in the pancreas by treating the mice with doxycycline and turn it off by withdrawing the drug.

Ying was a postdoctoral fellow in DePinho's lab at Dana-Farber before moving to MD Anderson after DePinho became president last September.

"These studies not only established that oncogenic Kras serves a tumor maintenance role, they allowed us to explore exactly how this occurs by extinguishing Kras in fully formed tumors," DePinho said.

Kras extinction causes tumor regression, deterioration

Pancreatic cancer progression is accompanied by the inactivation of a variety of tumor-suppressing genes. The team crossed its inducible Kras mice with others that had the tumor-suppressor p53 knocked out. Mice with either only iKras or iKras and deficient p53 were treated with doxycycline at three weeks of age.

  • All iKras mice with p53 deficiency died of pancreatic cancer between 11 and 25 weeks of age with median survival of 15 weeks.
  • The iKras/p53 mutant tumors had features commonly found in human pancreatic cancer, such as glandular tumor structures, invasion of local organs and metastases to the lung and liver.

Withdrawing doxycycline renders the iKras transgene extinct within 24 hours. Mice with iKras without p53 developed invasive pancreatic cancer by week eight after treatment.

When the researchers withdrew doxycycline at week nine:

  • Tumors swiftly regressed in size and visibly deteriorated after 48 hours.
  • After a week, MRI showed a reduction in tumor mass of about 50 percent, and PET/CT scans showed cessation of glucose uptake by the tumors.
  • Programmed cell death increased, tumor cell proliferation dropped and supportive tissue in the tumor - stroma - also was altered.
  • Signaling by downstream components of the Kras pathway, such as MAPK and mTOR, dropped.

Kras
'/>"/>

Contact: Scott Merville
smerville@mdanderson.org
713-792-0661
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Mutant gene identified that causes abnormal chromosome count, leading to cancer
2. Improved method for detecting mutant DNAs
3. Mutant Gene That Ups Risk for Ovarian Cancer May Aid Survival
4. Ganetespib showed activity in KRAS-mutant NSCLC as monotherapy and in combinations
5. Grassroots Campaign Drives toward Ending Malaria Deaths by 2015
6. Convenience drives US women to buy over-the-counter contraception in Mexico, study finds
7. Defensive Medicine Drives Wedge Between Patients/Physicians
8. Porsche Drives for Hope
9. Strength Based on Science Drives Glidewell Dental Lab's BruxZir Solid Zirconia
10. Researchers find pathway that drives spread of pediatric bone cancer in preclinical studies
11. Drug Targets Faulty Process That Drives Cystic Fibrosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... ... ... With TransCel from Pixel Film Studios users can simulate celluloid media transitions ... users have full control over camera position and angle within 3D space from start ... text, and more. With TransCel the possibilities are endless. , Users have full control ...
(Date:9/4/2015)... ... ... IVF New England, one of the largest and most successful fertility centers ... for women who wish to learn more about their fertility and egg freezing. , ... Elm Street, Manchester, NH from 6PM to 7PM , This hip, casual and informative ...
(Date:9/4/2015)... ... 2015 , ... A Union County charitable organization will host ... is a non-profit organization dedicated to offering Pilates scholarships to cancer patients to ... recover their mobility, strength, and range of motion following breast cancer surgery. ...
(Date:9/4/2015)... Maui HI (PRWEB) , ... September 04, 2015 , ... ... the best ways for couples to explore, revitalize and strengthen their ‘couple-ness,’” says ... and his team at Four Seasons Resort Maui, the island’s only Forbes Five Star ...
(Date:9/4/2015)... , ... September 04, 2015 , ... The USC Eye ... ranked number 9 nationwide by Doximity. Faculty, residents and staff are honored to ... pride in the quality of our ophthalmology residency program. Our faculty places a high ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios Releases TransCel, a New FCPX Transition 2Health News:IVF New England to Host ManchVegas New Hampshire Fertility Happy Hour on October 15, 2015 in Manchester for Women Who Wish to Learn More About Fertility and Egg Freezing 2Health News:Girl’s Night Out to Benefit Core Compassion Project, Located at the Beautiful, Morning Glory Farm 2Health News:Couples Season at Four Seasons Resort Maui Begins This Week With Best Hotel Rates of the Year through November 2Health News:Couples Season at Four Seasons Resort Maui Begins This Week With Best Hotel Rates of the Year through November 3Health News:USC Ophthalmology Residency Program Ranked in Top 10 by Doximity 2Health News:USC Ophthalmology Residency Program Ranked in Top 10 by Doximity 3
... Broader Patient Population -, LAKE FOREST, Ill., ... a global specialty pharmaceutical and medication delivery,company, announced ... (FDA),approved a new indication for Precedex(R), the company,s ... use of Precedex in,non-intubated patients requiring sedation prior ...
... - Dr. Jeffrey A. Niezgoda and Dr. Peter J. Sordi provide updates on ... Altrazeal(TM) - - John St. John, Ph.D. gives perspectives on design and ... ... (Amex: ULU ) --,Clinical updates and new case studies on the application ...
... Continue to Successfully Work,Together to Improve Health and ... our broken health care system,and escalating costs associated ... center stage in this year,s presidential campaigns, an,innovative ... health and reducing costs for people with diabetes., ...
... Genetics Company Singled Out for Pioneering Retail Genomics , ... ... announced today that the Personal Genome Service™ from 23andMe , ... chosen as the year,s most significant invention for its exceptional work ...
... of More Than 400,Generic Drugs for $9.99 and ... R.I., Oct. 30 Today,CVS/pharmacy, the nation,s leading ... program aimed at helping the uninsured during,this economic ... Health Savings Pass for a $10 annual enrollment ...
... $6 million dollars have been awarded to the State,s ... Medical Research (WAIMR), in support of a range of ... have shared 10 research grants from the National Health ... (ARC) announced last week placing the Institute,s success rate ...
Cached Medicine News:Health News:FDA Approves New Indication for Hospira's Precedex (Dexmedetomidine HCL) Injection 2Health News:FDA Approves New Indication for Hospira's Precedex (Dexmedetomidine HCL) Injection 3Health News:FDA Approves New Indication for Hospira's Precedex (Dexmedetomidine HCL) Injection 4Health News:ULURU Inc. Hosts Symposium on Altrazeal(TM) at the 23rd Annual Clinical Symposium on Advances in Skin & Wound Care 2Health News:ULURU Inc. Hosts Symposium on Altrazeal(TM) at the 23rd Annual Clinical Symposium on Advances in Skin & Wound Care 3Health News:Video: Diabetes Ten City Challenge Celebrates Three Years of Success: 2Health News:Video: Diabetes Ten City Challenge Celebrates Three Years of Success: 3Health News:Video: Diabetes Ten City Challenge Celebrates Three Years of Success: 4Health News:TIME Magazine Names 23andMe's Personal Genome Service 2008 Invention of the Year 2Health News:TIME Magazine Names 23andMe's Personal Genome Service 2008 Invention of the Year 3Health News:TIME Magazine Names 23andMe's Personal Genome Service 2008 Invention of the Year 4Health News:CVS/pharmacy Announces Pharmacy Health Care Savings Program Targeted at the Uninsured 2Health News:CVS/pharmacy Announces Pharmacy Health Care Savings Program Targeted at the Uninsured 3Health News:National grants further WA Medical Research 2
(Date:9/3/2015)... , Sept. 3, 2015  Cipla, a global ... the everyday needs of all patients, today announced that ... agreements to acquire two US-based companies, InvaGen Pharmaceuticals Inc., ... certain closing conditions, is valued at $550 million and ... from these transactions is over $200 million for the ...
(Date:9/3/2015)... Report Details Cancer ... and Sales Potentials Do ... new report gives you revenue predictions for that industry from ... R&D trends, opportunities, interviews and revenue forecasts. ... sales to 2025 at overall world market, submarket, product and ...
(Date:9/3/2015)... 3, 2015 About self-monitoring blood glucose ... home-based electronic device. It consists of a glucose ... glucose levels through radiowaves from the sensor to ... usage of self-monitoring blood glucose devices can improve ... undergo proper diabetes treatment. Technavio,s analysts ...
Breaking Medicine Technology:Cipla to acquire 100% of generic businesses in US for $550M 2Cipla to acquire 100% of generic businesses in US for $550M 3Cipla to acquire 100% of generic businesses in US for $550M 4Cipla to acquire 100% of generic businesses in US for $550M 5World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 2World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 3World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 4World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 5World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 6World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 7Global Self-monitoring Blood Glucose Devices Market 2015-2019 2
... 2011 / PRNewswire/ -- Fleming Pharmaceuticals, ... iodide product indicated for thyroid protection in radiation emergencies ... necessary to ramp up production to meet increased domestic ... an over-the-counter iodide solution which, when taken orally, saturates ...
... 21, 2011 Scott & White Healthcare today teleconferenced ... to repair an abdominal aortic aneurysm to conference attendees ... in Comparative Education) 2011, is one of the globe,s ... The procedure demonstrated the use of an endograft device ...
Cached Medicine Technology:Fleming Pharmaceuticals Now Ready to Step Up Production of Nuclear Radiation Safeguard, ThyroShield® 2Scott & White Healthcare Broadcasts Live Surgery to Sao Paolo, Brazil 2
If youre looking to expand your projection capabilities, without a major capital investment, consider Topcons CP-5D Chart Projector....
... The new FDA-Approved BV-1000 is ... subjective refraction system. With the ... new generation of refracting instruments. ... objective simultaneous binocular auto-refractor, auto-keratometer, ...
... As the worlds first truly ... ushered in the lensography age. Now ... Spectrum2 offers more accurate resultseven with ... is the only lens-analysis system that ...
... simplified focusing guidance system has ... to use of its type. Technicians ... LM-770 with a minimum of instruction. ... target lines to focus first. A ...
Medicine Products: